Questions Linger After FDA's Lab-Developed Tests Proposal
By Scott Danzis, Amy Leiser and Wade Ackerman · October 20, 2023, 5:33 PM EDT
On Sept. 29, and as widely anticipated, the U.S. Food and Drug Administration announced the publication of a proposed rule to clarify that lab-developed tests, or LDTs, are medical devices subject...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login